Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Cipla and Boehringer Ingelheim forge partnership to co-market three oral anti-diabetic drugs

Posted On: 2020-06-29 16:53:32


Cipla Limited (BSE: 500087; NSE: CIPLA EQ; hereafter referred to as "Cipla") and Boehringer Ingelheim India Pvt. Ltd. (BI) today announced their partnership in India to co-market three new oral anti-diabetics drugs Oboravo® (Empagliflozin), Oboravo Met® (Empagliflozin+Metformin) and Tiptengio® (Empagliflozin+Linagliptin)

Empagliflozin is approved for glucose-control in patients with type-2 diabetes; it is also approved for reducing the risk of cardiovascular death, in patients with type-2 diabetes and established cardiovascular disease. The Empagliflozin + Metformin combination Oboravo Met® can be given to newly diagnosed patients of type-2 diabetes who have higher baseline HbA1c levels.

The Empagliflozin + Linagliptin combination Tiptengio® is the world's first approved combination of an SGLT-2 inhibitor and DPP4 inhibitor. In addition to a strong effect on lowering blood sugar levels, it also addresses multiple pathophysiological defects in type 2 diabetes, and is a big step towards improved management of type 2 diabetes. It will also help in reducing the pill burden for patients and help improve adherence to the prescribed treatment.

As per the International Diabetes Federation, India is home to 77 million adults aged between 20 and 79 years with diabetes, ranking second behind China; and is poised to reach 134.2 million patients by 2045. Fortunately, while the number of patients is increasing, so is the awareness among the public to address it. The Indian diabetes market is valued at INR 1,45,451 million and is growing at 10.35% (IMS MAT May 2020) with the oral anti-diabetic market being valued at INR 1,07,354 million and growing at 11.34% (IMS MAT May 2020).

Commenting on the partnership, Nikhil Chopra, Executive Vice President & CEO - India Business, Cipla said, "We are committed to providing access to innovative medications that address unmet patient needs. Diabetes continues to be a focus area for Cipla and with a strategic partnership with Boehringer Ingelheim coupled with our strong brand building, patient access and reach capabilities, we will be at the forefront of providing holistic diabetes care."

Commenting on the expanded partnership, Mr. Sharad Tyagi, Managing Director - Boehringer Ingelheim India said, "We are excited about the expansion of our partnership with Cipla to provide pioneering medicines through the new oral anti-diabetics drugs. As a dedicated organization to the field of diabetes, we aim to provide wider access and innovative solutions to the medical fraternity and patients with one of the most comprehensive Diabetes portfolios in the country."

Shares of CIPLA LTD. was last trading in BSE at Rs.634.7 as compared to the previous close of Rs. 635.1. The total number of shares traded during the day was 196820 in over 5687 trades.

The stock hit an intraday high of Rs. 643.35 and intraday low of 631.6. The net turnover during the day was Rs. 125308777.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

HDFC ERGO Launches Corona Kavach Policy

Karnataka Bank reports earnings for Q1FY21

Gujarat Narmada Valley Fertilizers and Chemicals Ltd Board recommends Dividend of Rs. 5 for FY20

IRB Infra enters Eastern India territory

ITC Ltd board to announce Q1FY21 results on July 24, 2020

Manappuram Finance Ltd raises Rs. 178 crore through NCDs

BASF India Limited approves acquisition of BASF Performance Polyamides

Goa Carbon Ltd resumes operations at Goa plant from July 9, 2020

IRCTC board recommends final dividend of Rs. 2.50 for FY20

Ircon International Limited board recommends final dividend of Rs. 2.06

Rajapalayam Mills Ltd board to consider 1st quarter results on Aug 12, 2020

G N A Axles Ltd board to approve Q1FY21 results on July 17, 2020

Crompton Greaves Consumer Electricals Ltd board to announce 1QFY21 results on July 24, 2020

Modern Insulators Limited approves formation JV with Sikka Engineering Company for Railway EPC tender

SAIL Q4 consolidated PAT soars to Rs. 2647.52 crore

GNFC Q4 consolidated PAT jumps to Rs. 240.01 crore

Standard Surfactants Ltd reports Rs. 0.0258 crore loss in Q4FY2020

Future Consumer Ltd posts loss of Rs. 175.33 crore in Q4 FY2020

Meera Industries Ltd H2 loss at Rs. 1.10 crore

Somi Conveyor Beltings Ltd Q4 PAT jumps to Rs. 1.61 crore

IRCTC reports Rs. 150.60 crore PAT in Q4 FY2020

IRCON International Ltd reports consolidated Q4FY20 PAT of Rs. 115.40 crore

Euro Leder Fashion Ltd posts loss of Rs. 0.09 crore in Q4 FY20

Sangal Papers Ltd Q4 PAT at Rs. 0.46 crore

Nitin Castings Ltd Q4FY20 loss at Rs. 0.44 crore

Vardhman Polytex Ltd reports surge in Q4FY20 consolidated net profit to Rs. 161.58 crore

Lakshmi Vilas Bank Ltd Q4 net profit at Rs. 92.86 crore

Kanco Tea & Industries Ltd posts consolidated loss of Rs. 11.31 crore in Q4 FY20

Savita Oil Technologies Ltd Q4 FY20 net profit slips to Rs. 20.60 crore

Karnataka Bank Ltd Q1FY21 PAT surges to Rs. 196.38 crore

Unichem Laboratories Ltd receives ANDA approval for Baclofen Tablets

Vishal Fabrics Ltd Q4 PAT at Rs. 5.12 crore

Marico Ltd board to announce Q1FY21 results on July 27, 2020

GAIL to invest in Start-Ups operating in the area of Compressed Bio Gas, Solicitation Round open tm July 24, 2020

Tata Motors Group global wholesales at 91,594 in Q1 FY21

YES Bank Ltd board approves floor price of Rs. 12 for FPO

Newgen Software Technologies Ltd board to consider 1st quarter results on July 22, 2020

ICRA reaffirms rating of Puravankara Limited

NATCO settles on Lenalidomide for Canada

IndusInd Bank launches redesigned website to enhance customer experience

Muthoot M George Foundation launches Muthoot Vivahasammanam

Relaxo Foundation salutes the Unsung Warriors by contributing 25000 pairs of slippers to MCD sanitation workers

ITC Ltd.'s Sunfeast YiPPee! created a digital mosaic with pictures of Dhoni fans on the occasion of Dhoni's birthday

TRENT Ltd board to approve 1st quarter results on Aug 5, 2020

ITC Ltd forms subsidiary ITC IndiVision Limited

Celent Recognizes Majesco with XCelent Award for Depth of Service in the North American Policy Administration Systems 2020 Personal, Commercial and Specialty ABCD Vendor View Report

Sadbhav Engineering Ltd reports Rs. 886.63 crore PAT in Q4 FY20

NLC India Ltd's project in Andaman commissioned

Swarnsarita Gems Ltd Q4 consolidated PAT at Rs. 0.26 crore

PNB Housing Finance Ltd reworks business plan for FY2020-21







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019